Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Acoustic Connect demonstrates strong performance across technology excellence and customer impact criterias, reflecting ...
The agreement allows Pfizer to utilize Novavax’s Matrix-M adjuvant in up to two disease areas with its products. Under the ...
SOC Badge System and Organization Control New York, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Matrix Applications, LLC ("Matrix") ...
Nothing has teased what appears to be a new logo, sparking discussion among fans and tech enthusiasts. While the brand's ...
New design approach The Audi Q3 stands out with its two-stage split headlight design. The upper section houses the LED ...
Whether in the human body or on surfaces, bacteria protect themselves from outside attackers using biofilms. Physicist Eleonora Secchi is researching how these slime-like protective films are formed, ...
Zacks Investment Research on MSN
Novavax grants license for use of Matrix-M adjuvant to Pfizer
Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...
If Americans thought the 2016 and 2020 elections were messy, just wait until Mr. Artificial Intelligence shows up for the ...
Including everything from mad scientists to robotic villains, awe-inspiring heroes, and even iconic movie monsters, these are ...
InvestorsHub on MSN
Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer
Novavax (NASDAQ:NVAX) shares climbed about 5% on Tuesday after the biotech group disclosed a non-exclusive licensing ...
SCTIMST has developed Cholederm, a tissue graft scaffold from farm animal gall bladders, acclaimed as the world's first of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results